During the next two decades, nearly all type 1 diabetic patients develop retinopathy. Up to 21% of patients with type 2 diabetes have retinopathy at the time of first diagnosis of diabetes ...

Diabetes affects more than 101 million people in India today. The number is estimated to reach 125 million by the year 2045.

Treating diabetic retinopathy (DR ... The company is planning to initiate phase 1 trials by the third quarter of 2021 and move to phase 2 by the end of 2022. NovaGo has started a series B raise ...

Among 34,239 matched pairs, the risk of incident nonproliferative diabetic retinopathy was not different between patients taking empagliflozin or DPP-4 inhibitors (HR 1.04, 95% CI 0.94-1.15 ...

Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients ... 34 patients (17.1%) with mild non proliferative ...

Cataract surgery was associated with an increased risk of worsening diabetic retinopathy in ... complications: HR 1.45 (95% CI 1.09-1.92) and HR 1.58 (95% CI 1.17-2.13) Vitreous hemorrhage ...

Chronic hyperglycaemia is the primary cause of several macrovascular and microvascular diabetic complications, including cardiovascular disease, renal disease, diabetic retinopathy and peripheral ...

with millions of adults suffering from type 1 and type 2 diabetes. This high number of diabetic patients directly translates into an increased demand for diabetic retinopathy management and treatment ...

"We are pleased to initiate patient dosing in this important Phase 2 study, which evaluates VX-01 as a potential early intervention for diabetic retinopathy,” said Alek ... Eligible participants will ...

Diabetic retinopathy is a common diabetic eye diseasewhich is caused due to some changes in the blood vessels of the retina. The retina is a light-sensitive tissue that is present is the eye and ...